GLP-1 Drugs Tied to Lower Addiction Risk - Summary - MDSpire

GLP-1 Drugs Tied to Lower Addiction Risk

  • By

  • Kathryn Wighton

  • May 27, 2026

Share

Objective:

To evaluate the association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and the risk of substance use disorders (SUDs) among US veterans with type 2 diabetes, emphasizing the veteran population.

Key Findings:
  • GLP-1 RA initiation was associated with a lower risk for the composite endpoint of all incident SUDs (HR, 0.86), translating to about 7 fewer cases per 1,000 patients over 3 years, with modest absolute risk differences for individual SUDs.
Interpretation:

The findings suggest a potential role for GLP-1 receptor agonists in the context of SUDs, but do not support their use specifically for preventing or treating these disorders; they may inform clinical decisions regarding antihyperglycemic therapy.

Limitations:
  • The study is observational and subject to possible residual confounding and misclassification, which may affect the reliability of the findings.
Conclusion:

The study indicates that GLP-1 RAs may be relevant in selecting antihyperglycemic therapy for patients with type 2 diabetes at risk for SUDs, but any advantages must be weighed against known adverse effects, emphasizing the need for careful clinical consideration.

Original Source(s)

GLP-1 Drugs Tied to Lower Addiction Risk

  • by Kathryn Wighton

  • May 27, 2026

Related Content

Gender-Diverse Youths Reported More Psychotic-Like Experiences

Longitudinal cohort data linked bullying and persistently unsupportive state gender-identity policies with worsening psychotic-like experiences among gender-diverse youths.

Anxiety, Depression Higher in Health Workers

National survey data also suggested lower treatment rates among health care workers with either condition.

Body Dysmorphic Symptoms Linked to Brain Structure

Researchers reported gender-specific associations in visual and limbic brain regions among healthy adults with subclinical body dysmorphic symptoms.